腫瘍細胞市場を循環させる | サイズ分析・成長・展望 (2022-2030)

Table of Content

1.Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Circulating Tumor Cells
1.5.Global Circulating Tumor Cells: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in brief
1.9.Parent Market Overview
1.10. Overall Circulating Tumor Cells Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average primary breakdown ratio

2.Market Dynamics

2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact forces on market dynamics
2.3.2.Impact forces during the forecast years
2.4.Industry Value Chain
2.4.1.Upstream analysis
2.4.2.Downstream analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Regulatory Analysis
2.10. Porter\'s Analysis
2.10.1.Supplier Power
2.10.2.Buyer Power
2.10.3.Substitution Threat
2.10.4.Threat from New Entry
2.10.5.Competitive Rivalry
2.11. PESTEL Analysis
2.12. Political Factors
2.13. Economic Factor
2.14. Social Factors
2.15. Technological Factor
2.16. Environmental Factors
2.17. Legal Factor

3.Global Circulating Tumor Cells Market Segmentation, by Revenue (USD Billion), (2023-2030)

3.1.By Technology
3.1.1.CTC Detection And Enrichment Methods
3.1.1.1.Immunocapture (Label-Based)
3.1.1.1.1.Negative Enrichment
3.1.1.1.2.Positive Enrichment
3.1.1.2.Size-Based Separation (Label-Free)
3.1.1.2.1.Membrane-Based
3.1.1.2.2.Microfluidic-Based
3.1.1.3.Density-Based Separation (Label-Free)
3.1.1.4.Combined Methods (Label-Free)
3.1.1.5.Others
3.1.2.CTC Detection Methods
3.1.2.1.SERS
3.1.2.2.Microscopy
3.1.2.3.Others
3.1.3.CTC Analysis
3.2.By Specimen
3.2.1.Blood
3.2.2.Bone Marrow
3.2.3.Other Body Fluids
3.3.By Product
3.3.1.Kits & Reagents
3.3.2.Blood Collection Tubes
3.3.3.Devices or Systems
3.4.By Application
3.4.1.Clinical/ Liquid Biopsy
3.4.1.1.Risk Assessment
3.4.1.2.Screening and Monitoring
3.4.2.Research
3.4.2.1.Cancer Stem Cell & Tumorogenesis Research
3.4.2.2.Drug/Therapy Development
3.5.By End Use
3.5.1.Hospital and Clinics
3.5.2.Diagnostic Centers
3.5.3.Research and Academic Institutes
3.5.4.Others

4.Global Circulating Tumor Cells Market Overview, By Region

4.1. North America Market Revenue (USD Billion), by Countries, (2023-2030)
4.1.1. US
4.1.1.1.By Technology
4.1.1.2.By Specimen
4.1.1.3.By Product
4.1.1.4.By Application
4.1.1.5.By End Use
4.1.2.Canada
4.1.3.Mexico
4.2.Europe Market Revenue (USD Billion), by Countries, (2023-2030)
4.2.1.France
4.2.2.UK
4.2.3.Germany
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Market Revenue (USD Billion), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASIAN
4.4.Latin America Market Revenue (USD Billion), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Market Revenue (USD Billion), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa

5.Global Circulating Tumor Cells Market Revenue: Competitive Analysis, 2021

5.1.Key strategies by players
5.2.Revenue (USD Billion and %), By manufacturers, 2022
5.3.Player Positioning by Market Players, 2022

6.Competitive Analysis

6.1.Fluxion Biosciences Inc.
6.1.1.Business Overview
6.1.2.Business Financials (USD Billion)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.Swot Analysis
6.2.Bio-Techne
6.3.Precision Medicine Group, LLC.
6.4.QIAGEN
6.5.Aviva Systems Biology Corporation
6.6.BIOCEPT, Inc.
6.7.Thermo Fisher Scientific
6.8.Greiner Bio One International GmbH
6.9.Ikonisys Inc.
6.10.Miltenyi Biotec
6.11.IVDiagnostics
6.12.BioFluidica
6.13.Canopus Bioscience Ltd.
6.14.Biolidics Limited
6.15.Creativ MicroTech, Inc.
6.16.LungLife AI, Inc.
6.17.Epic Sciences
6.18.Rarecells Diagnostics
6.19.ScreenCell
6.20.Menarini Silicon Biosystems
6.21.LineaRx, Inc. (Vitatex, Inc.)
6.22.Sysmex Corporation
6.23.STEMCELL Technologies, Inc.
6.24.Cynvenio Biosystems

7.Market Research Findings & Conclusion
Disclaimer

Disclaimer